Drug Discovery ELRIG 2026

Join InSphero at Drug Discovery ELRIG 2026

Join us at ELRIG Drug Discovery 2026 in London, where the drug discovery community comes together to explore the latest technologies and approaches shaping preclinical research.

We’re looking forward to sharing how human-relevant 3D cell culture models can be combined with scalable imaging and multimodal workflows to generate more physiologically relevant, decision-ready data for drug discovery.

Connect with our team and explore how these approaches can support more informative and scalable screening workflows.

Discover all our activities during ELRIG Drug Discovery 2026, October 14–15.

London’s calling, see you there!

 

Meet our Team at Drug Discovery ELRIG 2026

Olivier Frey

Olivier Frey, PhD

Chief Operating Officer & Chief Technology Officer

Christine Schwenk

Business Development Manager

Scientific Talks at Drug Discovery ELRIG 2026

Engineering end-to-end multi-modal workflows in 3D cell cultures

Date: Wednesday, October 14 2026 | 14:40 – 15:10 

Location: Auditorium 2

Theme: Integrating experimental design, lab-in-the-loop and AI towards translatable discovery

Olivier Frey

Olivier Frey, PhD

Chief Operating Officer & Chief Technology Officer

Industry Insider with Ramona Optics - Scalable whole-plate real-time video acquisition of calcium dynamics in 3D human neural microtissues for functional drug screening

Date: Thursday, October 15 2026 | 12:40 – 12:55 

Location: Auditorium 2

Theme: The power of imaging in Drug Discovery 

Christine Schwenk

Business Development Manager

Scientific Poster at Drug Discovery ELRIG 2026

3D InSight™ Human Neural Microtissues: Ready-to-use 3D cortical neural spheroids for scalable CNS safety and neurotoxicity screening

Date: October 14 & 15 2026 | 13:30 – 14:00 

Location: Exhibition Area

Poster: #302

Christine Schwenk

Business Development Manager

Drug Discovery ELRIG 2026 Resources

Scalable Pharmacological Profiling of 3D InSight™ Human Neural Microtissues Using High-Density MEAs
3D InSight™ Human Neural Microtissues: Ready-to-use 3D cortical neural spheroids for scalable CNS safety and neurotoxicity screening  
Toward Patient-Relevant DILI Testing: Integrating Intrinsic Liver Vulnerability with Systemic Metabolic Cues
ZEISS Lightfield 4D for High-Content Tumor Microtissue Screening: From Reliable and Scalable 3D Models to Quantitative Insights
Brochure 3D InSight™ Human Neural Microtissues
A scalable microarrayed organoid platform for precision modeling of intestinal epithelial damage and recovery
Studying Fibrosis using 3D InSight Human MASH Microtissues Leveraging ZEISS Lattice Lightsheet 7 for 3D High-Content Analysis
Scalable Whole-Plate Calcium Imaging of Human iPSC-Derived Neural Spheroids for Drug Screening and Neurotoxicity Assessment

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

Webinar registration

Fill in the form below to register

View resource

Fill in the form below to view this resource